The biologics segment, already growing in importance before the COVID-19 pandemic, is expanding even faster in its wake with respect to both the level of investment and number of new startups. PCI Pharma Services is keeping pace with the changes and remaining focused on addressing the growing need for outsourcing support by these new small and medium-sized biopharmaceutical companies.
Available Downloads
-
An Evolving Biologics Landscape and Driving Innovation and Opportunity
Download
